Physiological
sensing
Approaches to the integrity and utility of physiological measurements.
THE MEASUREMENTVITALSIGNX / SENSING & MONITORING
Physiological sensing, calibration, and monitoring innovation from EndoscopeX.
01 / OUR FOCUS
VitalSignX brings a dedicated identity to EndoscopeX’s physiological sensing and monitoring focus.
Approaches to the integrity and utility of physiological measurements.
THE MEASUREMENTConsidering measurement reliability in the conditions where monitoring is intended to operate.
THE FOUNDATIONConnecting measurements with the context needed to make healthcare information more useful.
THE APPLICATIONPotential applications include patient monitoring, physiological measurement, and connected care platforms. This is a nonconfidential overview of areas of interest.
02 / A FOCUSED EVALUATION
A technology discussion should make the evidence, assumptions, and remaining work clear.
Intended use, operating conditions, available evidence, and known limitations.
Technology-specific filing status, ownership, scope, and associated obligations.
Current stage, validation needs, integration requirements, and development dependencies.
Specific technologies and supporting materials can be discussed under an agreed confidentiality framework.
Start a focused discussion03 / THE BROADER PORTFOLIO
VitalSignX focuses on sensing and monitoring. EndoscopeX brings the wider medical-technology portfolio, intellectual-property strategy, and company leadership into view.
Explore EndoscopeX

FOUNDER-LED
Abdul Muhsin leads EndoscopeX’s technology and commercial strategy, with experience across enterprise healthcare, digital health, and connected care.
Meet the founder at EndoscopeXLICENSING / PARTNERSHIP / STRATEGIC INTEREST
Tell us about your organization, your area of interest, and the application you have in mind.
Request a confidential discussion abdul@endoscopex.comStart with a nonconfidential introduction. Where there is mutual interest, we can agree the scope and confidentiality arrangements for further review.
Company and portfolio opportunities